DMCC Speciality Chemicals Q1 Results: Net Profit Surges to ₹2,040.52 Lakhs YoY

3 min read     Updated on 11 Aug 2026, 03:03 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

DMCC Speciality Chemicals Limited reported its unaudited Q1 FY27 results for the quarter ended June 30, 2026, with standalone total income from operations more than doubling to ₹25,329.33 lakhs from ₹12,729.76 lakhs YoY. Standalone net profit after tax surged to ₹2,040.52 lakhs compared to ₹775.31 lakhs in the year-ago quarter, while basic and diluted EPS rose to ₹8.18 from ₹3.11. Consolidated results were in line with standalone performance, with net profit after tax at ₹2,040.52 lakhs. The results were approved by the Board of Directors on August 10, 2026, following a limited review by statutory auditors.

powered bylight_fuzz_icon
47986400

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals Limited reported a significant year-on-year improvement in its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's standalone total income from operations more than doubled to ₹25,329.33 lakhs from ₹12,729.76 lakhs in the corresponding quarter of the previous year, reflecting robust growth in its chemicals manufacturing and sales segment. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 10, 2026, and have been prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013.

Standalone Financial Performance

The standalone financial results for the quarter ended June 30, 2026 demonstrate a strong recovery and growth trajectory across all key profitability metrics. Net profit before tax stood at ₹2,721.14 lakhs, compared to ₹1,102.66 lakhs in Q1 of the prior year. Net profit after tax came in at ₹2,040.52 lakhs, a substantial increase from ₹775.31 lakhs in the year-ago quarter. Total comprehensive income for the period was ₹1,997.91 lakhs versus ₹716.75 lakhs in the prior year quarter.

The following table summarises the standalone financial results:

Metric: Q1 FY27 (30.06.2026) Unaudited Q4 FY26 (31.03.2026) Audited Q1 FY26 (30.06.2025) Unaudited FY26 Year Ended (31.03.2026)
Total Income from Operations (₹ Lakhs): 25,329.33 17,779.23 12,729.76 58,296.23
Net Profit before Tax (₹ Lakhs): 2,721.14 1,082.13 1,102.66 3,896.23
Net Profit after Tax (₹ Lakhs): 2,040.52 766.40 775.31 2,733.18
Total Comprehensive Income (₹ Lakhs): 1,997.91 761.90 716.75 2,673.18
Equity Share Capital (₹ Lakhs): 2,493.99 2,493.99 2,493.99 2,493.99
Basic & Diluted EPS (₹): 8.18 3.07 3.11 10.96

Consolidated Financial Performance

On a consolidated basis, the company's performance closely mirrored the standalone results. Total income from operations for the quarter ended June 30, 2026 stood at ₹25,330.97 lakhs, compared to ₹12,741.73 lakhs in the year-ago quarter. Consolidated net profit after tax was ₹2,040.52 lakhs versus ₹775.52 lakhs in Q1 of the prior year. Total comprehensive income on a consolidated basis was ₹1,997.91 lakhs for the current quarter.

The following table presents the consolidated financial highlights:

Metric: Q1 FY27 (30.06.2026) Unaudited Q4 FY26 (31.03.2026) Audited Q1 FY26 (30.06.2025) Unaudited FY26 Year Ended (31.03.2026)
Total Income from Operations (₹ Lakhs): 25,330.97 17,780.38 12,741.73 58,261.31
Net Profit before Tax (₹ Lakhs): 2,721.14 1,081.14 1,102.97 3,896.24
Net Profit after Tax (₹ Lakhs): 2,040.52 765.41 775.52 2,732.87
Total Comprehensive Income (₹ Lakhs): 1,997.91 763.17 715.97 2,682.93
Equity Share Capital (₹ Lakhs): 2,493.99 2,493.99 2,493.99 2,493.99
Other Equity (₹ Lakhs): 22,276.42 22,323.74
Basic & Diluted EPS (₹): 8.18 3.07 3.11 10.96

Key Notes and Disclosures

Several notable disclosures accompanied the quarterly results:

  • The company operates in a single segment—manufacturing and sale of chemicals—and therefore segment-wise disclosure requirements under Ind AS 108 on Operating Segments are not applicable.
  • The statutory auditors conducted a limited review of the financial results for the quarter ended June 30, 2026 and issued an unmodified review opinion.
  • The figures for the quarter ended March 31, 2026 represent balancing figures between the audited full-year figures and the unaudited nine-month figures ended December 31, 2025.
  • The full format of the financial results is available on the websites of BSE Limited, the National Stock Exchange of India Ltd., and the company's website.

The results were signed off by Bimal Latesh Goudsal, Managing Director & Chief Executive Officer (DIN: 00242783), at Mumbai on August 10, 2026.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.55%+8.63%+14.57%+24.03%-9.58%-1.29%

What specific operational drivers or product mix changes contributed to the doubling of revenue, and are these growth factors sustainable for the remainder of FY27?

How does the company plan to manage input cost volatility in the specialty chemicals sector to protect the expanded profit margins observed in Q1?

Given the significant year-on-year improvement, what is the management's guidance on capital expenditure or capacity expansion plans to capitalize on this demand surge?

DMCC Speciality Chemicals
View Company Insights
View All News
like19
dislike

DMCC Speciality Chemicals Q1 Results: Net Profit Jumps to 204M Rupees YoY

1 min read     Updated on 10 Aug 2026, 03:14 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

DMCC Speciality Chemicals reported Q1 net profit of 204M rupees, more than doubling from 78M rupees YoY. Revenue surged to 2.5B rupees from 1.27B rupees in the same period last year. EBITDA nearly doubled to 341M rupees from 169M rupees YoY, while EBITDA margin improved to 13.5% from 13.29% on a year-on-year basis.

powered bylight_fuzz_icon
47900641

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals posted a significant year-on-year improvement across all key financial metrics in its latest quarterly results. Net profit more than doubled to 204M rupees compared to 78M rupees in the same quarter of the previous year, underscoring a robust turnaround in profitability. Revenue nearly doubled as well, rising to 2.5B rupees from 1.27B rupees YoY, reflecting strong top-line momentum across the business.

Financial Performance Highlights

The company's operational performance was equally noteworthy, with EBITDA surging to 341M rupees from 169M rupees on a year-on-year basis. The EBITDA margin also expanded, improving to 13.5% from 13.29% in the corresponding prior-year period, indicating better cost efficiency relative to revenue growth. The following table summarises the key financial metrics for the quarter:

Metric: Q1 Current Q1 Previous (YoY)
Net Profit: 204M rupees 78M rupees
Revenue: 2.5B rupees 1.27B rupees
EBITDA: 341M rupees 169M rupees
EBITDA Margin: 13.5% 13.29%

Key Takeaways

The quarterly results highlight the following notable developments for DMCC Speciality Chemicals:

  • Net profit grew sharply to 204M rupees from 78M rupees YoY
  • Revenue nearly doubled to 2.5B rupees from 1.27B rupees YoY
  • EBITDA rose to 341M rupees from 169M rupees YoY
  • EBITDA margin expanded to 13.5% from 13.29% YoY

The combination of strong revenue growth and improved EBITDA margins reflects the company's ability to scale operations while maintaining cost discipline. The near-doubling of revenue alongside a meaningful increase in absolute EBITDA indicates that the business has grown both in scale and operational efficiency on a year-on-year basis.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.55%+8.63%+14.57%+24.03%-9.58%-1.29%

What specific product segments or customer contracts drove the near-doubling of revenue, and are these growth drivers sustainable in the next quarter?

How does the 0.21% expansion in EBITDA margin compare to industry peers, and what operational efficiencies contributed to this improvement?

Will DMCC Speciality Chemicals reinvest the increased cash flow into capacity expansion or R&D, and what is the expected timeline for these initiatives?

DMCC Speciality Chemicals
View Company Insights
View All News
like18
dislike

More News on DMCC Speciality Chemicals

1 Year Returns:-9.58%